Anti-cytokeratin 19 reacts with a wide variety of epithelia and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although follicular carcinoma is also labeled by this antibody approximately 50%-60% of the time.
Anti-cytokeratin 19 reacts with a wide variety of epithelia and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although follicular carcinoma is also labeled by this antibody approximately 50%-60% of the time.
http://www.cellmarque.com/Cell Marque
Anti-cytokeratin 19 reacts with a wide variety of epithelia and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although follicular carcinoma is also labeled by this antibody approximately 50%-60% of the time.
